Multimodal Imaging Market Growth Is Accelerating As Industry Transformation Continues
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Multimodal Imaging Market Growth From $4.61 Billion In 2026 To $6 Billion By 2030 At A CAGR Of 6.8%
The multimodal imaging market size has shown robust expansion in recent years. It is projected to grow from $4.32 billion in 2025 to $4.61 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.6%. The historical growth experienced by this market can be attributed to the advancement of diagnostic imaging, an increase in cancer screening programs, the expansion of hospital imaging infrastructure, improvements in detector technology, and heightened clinical imaging demand.
The multimodal imaging market is poised for significant expansion over the coming years. Projections indicate it will reach a valuation of $6 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.8%. This anticipated growth stems from several factors, including an increased demand for precision diagnostics, the escalating burden of chronic diseases, the integration of AI imaging analytics, the proliferation of hybrid imaging systems, and the broadening availability of imaging as a service. Key developments expected during this period encompass hybrid PET/MR imaging systems, integrated multi-modality diagnostics, AI-assisted image fusion, cloud-based imaging analytics, and sophisticated multimodal visualization software.
Download A Free Sample Report For Comprehensive Market Insights:
Multimodal Imaging Market Demand Drivers: What Is Fueling Industry Growth?
The increasing need for prompt and precise disease identification is projected to fuel the expansion of the multimodal imaging market in the future. Early and accurate disease diagnosis involves identifying illnesses in their initial phases with considerable accuracy, leveraging medical information and advanced techniques to facilitate prompt treatment and improved patient results. This surge in early and accurate disease diagnosis stems from individuals desiring prompt and exact detection of conditions for superior treatment and outcomes, thereby allowing healthcare practitioners to identify ailments considerably sooner than previously possible. Multimodal imaging aids in early and accurate disease diagnosis by enabling the integration of various medical imaging methods to pinpoint diseases with greater accuracy. For example, in October 2024, the National Health Service England, a UK-based public body, reported that as of March 2024, early diagnosis rates had surpassed pre-pandemic levels by 2.4% points and were 0.8% points greater than the preceding year, according to Rapid Cancer Registration Data. Consequently, the escalating demand for early and accurate disease diagnosis is propelling the expansion of the multimodal imaging market.
Multimodal Imaging Market Categorization By Product Type And Application
The multimodal imaging market covered in this report is segmented –
1) By Product: Multimodal Imaging Equipment; Reagents; Software
2) By Technology: Positron Emission Tomography (PET) Or Computed Tomography (CT) Systems; Single Photon Emission Computed Tomography Or Computed Tomography (CT) Systems; Positron Emission Tomography (PET) Or Magnetic Resonance (MR) Systems; Other Technologies
3) By Application: Oncology; Cardiology; Neurology; Ophthalmology; Musculoskeletal Disorders; Other Applications
4) By End-User: Hospitals; Diagnostic Imaging Centers; Other End-Users
Subsegments:
1) By Multimodal Imaging Equipment: Magnetic Resonance Imaging Scanner; Computed Tomography Scanner; Positron Emission Tomography Scanner; Single Photon Emission Computed Tomography Scanner; Optical Imaging System; Photoacoustic Imaging System; Hybrid Imaging System
2) By Reagents: Contrast Agents; Radiopharmaceuticals; Fluorescent Dyes; Molecular Probes
3) By Software: Image Processing Software; Analysis And Visualization Software; Data Management Software; Workflow And Reporting Software
Multimodal Imaging Market Innovation Trends: Which Developments Are Transforming The Industry?
Leading companies active in the multimodal imaging market are increasingly emphasizing breakthroughs in artificial intelligence and machine learning for analyzing and interpreting images. This includes AI-assisted image segmentation, which enables the automatic identification of anatomical structures and areas of interest across various imaging methods. AI-assisted image segmentation involves using artificial intelligence algorithms to automatically partition images into meaningful sections, a task that traditionally required human experts to manually trace. For example, in September 2025, Revvity, Inc., a US-based company specializing in preclinical imaging solutions, introduced its Living Image Synergy AI multimodal analysis software. This software provides a unified, AI-powered platform for the seamless analysis of in vivo imaging data across optical, microCT, ultrasound, and other modalities. It diminishes data inconsistencies by centralizing workflows and eliminating the need for multiple separate tools. Moreover, it integrates advanced AI algorithms to automate image segmentation and the quantification of regions of interest, thereby improving accuracy and reproducibility. Intuitive co-registration and automated procedures further reduce manual effort and the time required for analysis.
Multimodal Imaging Market Company Landscape And Strategic Competition
Major companies operating in the multimodal imaging market are Samsung Medison Co. Ltd., Analogic Corporation, Alcon Inc., Hologic Inc., Sofie Biosciences Inc., ShanghAI United Imaging Healthcare Co. Ltd., Topcon Corporation, Agfa-Gevaert Group, Heidelberg Engineering GmbH, Optos plc, RefleXion Medical Inc., Neusoft Corporation, Infraredx Inc., MinFound Medical Systems Co. Ltd., Neusoft Medical Systems Co. Ltd., Spectrum Dynamics Medical LLC, Konica Minolta Healthcare Americas Inc., Esaote S.p.A., MR Solutions Ltd., MILabs B.V., NIDEK Co. Ltd., Kowa Company Ltd., and Positron Corporation.
Access The Complete Multimodal Imaging Market Report:
Multimodal Imaging Market Largest Region By Revenue And Market Share
North America was the largest region in the multimodal imaging market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multimodal imaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model